Specifically, GREB1, which is coexpressed with but not regulated by MYCN, also contributes to the pathobiology of MNA+ NB, specifically through a previously unknown mechanism involving MYO1B-mediated MIF secretion to enhance the aggressiveness of MNA+ NB independently of MYCN. The gene discussed is MYCN; the disease is neuroblastoma.